Back

The safe hematocrit threshold during cardiopulmonary bypass in children with cyanotic congenital heart disease: a retrospective study

31 August 2025 (11:15 - 12:09)
Organised by: Logo
Congress Presentation Part of: Topics in paediatric cardiology (2) Paediatric Cardiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Qindong Liu

Beijing (China)

8 More presentations in this session

Presentation thumbnail
Interrelationship of cardiovascular risk factors in early adulthood. The role of endothelial glycocalyx
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Idiopathic recurrent pericarditis in children and adults:clinical and diagnostic differences
Professor A. Brucato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Small patients, significant findings: electropathology of Bachmann Bundle in pediatric patients
Doctor M. Linderhof (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Maternal perception and acceptability of systematic echocardiography of newborns
Miss C. Gammelvind (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Adapting the reveal lite score to pediatric populations through an artificial intelligence model trained in REHIPED registry patients
Doctor J. Playan Escribano (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Topics in paediatric cardiology (2)

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Optimization of the optimal anticoagulation strategy during cardiopulmonary bypass for neonates with congenital heart disease: a single-center randomized controlled study
thumbnail
Congress Presentation
Deciphering postoperative hemodynamics in pediatric intensive care: insights from patient-specific computational fluid dynamics models for congenital heart disease
thumbnail
Congress Presentation
Efficacy of intravenous iron therapy compared to usual treatment in iron deficient adult cyanotic congenital heart disease patients for improvement in clinical outcomes at three months

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources